The clinical research industry is becoming revolutionized by mobile devices. Merge announced their eClinical OS Marketplace today at DIA. Here's the press release:
Merge Unveils eClinical OS(TM) Marketplace and Mobile Applications at DIA
Customers Will Benefit From Electronic Document Translation, Study-Specific Training Videos, and Real Time Mobile Analytics and Visualization
CHICAGO, June 21, 2013 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced the eClinical OS™ Marketplace, extending its clinical trial platform to connect customers with premier industry service providers. In the latest release of eClinical OS, Marketplace allows customers to request and receive services directly from within study workflows, further enabling study sponsors and CROs to run studies more efficiently. The newest release also introduces Trial Connect, a new mobile alerts and reporting application for accessing study metrics on the go.
This connectivity further supports the company's focus on improving study efficiency with shorter deployment times and more cost effective trial design. Users will be able to electronically request and receive document language translation, embed interactive study-specific training and patient education videos, and access real-time clinical data visualization, analytics and reporting through any mobile device.
"We're integrating and delivering services from other best in class providers via eClinical OS; creating unprecedented value and efficiency in the industry's leading digital clinical platform," said Zaher El-Assi, General Manager, eClinical Solutions for Merge.
"New releases of our platform will both advance eClinical OS features and aggressively expand what's possible for our customers within a single, cloud study solution via the Marketplace. The aggregation of premium services and software – true partnerships that provide seamless benefit to users in the cloud – enable us to deliver efficiencies that significantly improve and accelerate the clinical trials process."
Merge integrates with TransPerfect to offer electronic transmission of documents and system text for translations within eClinical OS
Merge and TransPerfect, a premier provider of translation services to pharmaceutical, biotechnology, and healthcare companies, have partnered to streamline the translation of critical documents for global studies.
Expanding its commitment to global trials beyond support for 25 languages and real-time helpdesk interpreting, Merge eClinical now offers on-demand translation of Case Report Forms and supporting documents.
"Merge eClinical customers can now seamlessly request the translation of Case Report Forms, and their supporting documents directly from within their eClinical OS study," explained El-Assi.
Translation is available by clicking a link next to an uploaded document. The document is pushed to TransPerfect for translation, then returned within eClinical OS.
"TransPerfect is a prime example of what we're doing with the eClinical OS Marketplace," continued El-Assi. "Take a premium third-party capability, which used to require a separate upload, purchase, and delivery process, and embed it within the eClinical OS study workflow. We're able to remove steps, decrease costs and margin for error, and increase efficiency."
Merge partners with Comprehend Systems to provide clinical data visualization, analytics and reporting
Merge and Comprehend Systems, Inc., a leading provider of end-to-end clinical data insights, partner to enable real-time analytics and visualization across multiple studies tracked within eClinical OS.
"Our partnership with Comprehend improves the way clinical researchers access, understand, explore and analyze data," said El-Assi. "Non-technical users can create ad-hoc reports and visualizations in real-time, from numerous sources and across different trials."
Merge eClinical OS customers will be able to use Comprehend Clinical™ analytics tools, including highlights, filters, graphs and visualizations to create, save, and share eClinical OS reports and interactive dashboards.
"Comprehend specializes in bringing intuitive data insights to clinical trials," added El-Assi, "and is a perfect fit for eClinical OS, which exists to improve efficiency, support better decisions, and drive results."
Merge integrates with Emmi Solutions to provide interactive training tools within eClinical OS
Merge and Emmi Solutions, a market leader in interactive solutions to achieve meaningful business and clinical outcomes, will partner to integrate high-quality, interactive training presentation within eClinical OS.
"With Emmi, our customers can create and embed interactive, on-demand training modules within eClinical OS workflows," continued El-Assi. "eClinical OS already allows customers to build entire training programs, design and deliver comprehension tests, and track results."
"We expect the combination of using interactive content and our strong training and competency tracking features to improve study performance for our customers, while supporting FDA and quality compliance requirements."
Merge eClinical OS customers will be able to embed their own content, or take advantage of content made available in eClinical OS by Merge or other approved partners. Training requirements are presented to users within their eClinical OS workflow, based on site, role, or other training criteria.
"Our goal is to offer not only the tools customers need to develop and track training requirements, but for our Marketplace to serve as the leading online content provider for everything clinical trials," concluded El-Assi.
Merge releases new mobile application for eClinical OS
In addition to aggregating premier service offerings to streamline the clinical trials process, the latest version of eClinical OS brings Trial Connect, a mobile alerts and reporting companion application, allowing users to review study data directly from any mobile web-enabled device.
"With eClinical OS Trial Connect, our clients now have a convenient way to stay connected with their team and their active studies while on the go," said El-Assi. "Whether they need to share metrics with key stakeholders, or just want to stay in the loop while traveling, they now have critical study data at their fingertips."
Merge will be showcasing eClinical OS' latest enhancements at the upcoming DIA Annual Meeting in Boston, MA, booth #619.
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare. Merge's enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 25 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.
About Comprehend Systems
Comprehend Systems, Inc. was formed in 2010 in California by an entrepreneurial team that has several decades of combined experience with clinical trials and software development. The company's mission is to create Software-as-a-Service tools that help understand, explore, and analyze data across multiple, disparate datasources. For more information, visit comprehend.com.
About Emmi Solutions
Emmi's proprietary interactive communication methodology delivers actionable health information to patients via multiple modalities – including computers, mobile phones and tablets – at key moments across the continuum of care. Emmi's ability to connect with patients in language they understand at a time they are ready to learn and through the devices they already own has been demonstrated to help healthcare providers reduce costs, increase revenue and improve outcomes. The patented platform allows providers to track the delivery and consumption of information to measure the clinical and financial impact of patient engagement and meet regulatory guidelines. The web-based platform requires no installation or maintenance and can be used in stand-alone mode or fully integrated into existing systems. Learn more by visiting emmisolutions.com.
TransPerfect is the world's premier provider of translation services to pharmaceutical, biotechnology, and healthcare companies. The team is comprised of linguistic experts with proven technical and scientific know-how, supported by ISO 9001:2008 and EN 15038:2006 certified quality management system. For more information, visit transperfect.com
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words "will," "believes," "intends," "anticipates," "expects" and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.